Original scientific paper
Clinical Experience with Ex-Press Mini Glaucoma Shunt Implantation
Morena Gavrić
Nikica Gabrić
Ana Čović
Abstract
In this prospective study we wanted to report our experience and to evaluate the effiacacy and safety of Ex-press
Mini-Glaucoma Shunt implantation under a superficial scleral flap, as a newly and improved surgical technology in a
treatment of POAG(Primary open-angle glaucoma) and refractory glaucoma. 44 eyes (35 patients) underwent an implantation
of Ex-Press Mini Glaucoma Shunt. We had 21 patiens with POAG (60%) and 14 patients with PEXG-pseudoexfoliation
glaucoma (40%). The follow-up period was 8.62+7.48 months (range 2–22 months). Main outcome measures
included postoperative IOP control, postoperative medications and early postoperative complications. The IOP was measured
in the following postoperative time-points of 1 day, 1 week, 1, 3, 6, 9 and 12 months. The mean IOP values 1 year
postoperatively were reduced for 52.8% compared to preoperative values and the use of medications were reduced for
77%. We had complications like postoperative hypotony (3.5%), choroidal ablation (7%), intraocular hemorrhage (3.5%)
and postoperative shunt closure (3.5%). The Ex PRESSMini Glaucoma Shunt implanted under a superficial scleral flap
is relatively safe and effective surgical procedure and provides satisfactory IOP control and medication reduction. However,
device related complications remain still a problem.
Abbreviations: POAG – Primary open-angle glaucoma, PEXG – Pseudoexfoliation glaucoma, IOP – Intraocular
pressure
Keywords
Ex-Press Mini Glaucoma Shunt; glaucoma
Hrčak ID:
72221
URI
Publication date:
25.9.2011.
Visits: 1.020 *